Biopharmaceutical Company Announces Enters Into Major Financial Transaction With Life Sciences Giant
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility.
Disclaimer: This article is for informational purposes only and does not constitute financial, commercial, or promotional advice. The information contained within is intended to provide a detailed account of recent business transactions between Esperion, OMERS Life Sciences, and their implications without advocating for any speci…